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Objective. Subclinical gut inflammation has been
demonstrated in patients with ankylosing spondylitis
(AS). This study was undertaken to determine the
frequency of regulatory CD4CD25high T cells (Treg
cells) and to evaluate Treg cell–related cytokines
(interleukin-2 [IL-2], transforming growth factor 
[TGF], and IL-10) and transcription factors (FoxP3
and STAT-5) in the ileum of patients with AS.
Methods. Quantitative gene expression analysis,
by reverse transcriptase–polymerase chain reaction, of
Treg-related cytokines (IL-2, TGF, and IL-10) and
transcription factors (STAT-5 and FoxP3) was per-
formed on ileal biopsy specimens from 18 patients with
AS, 15 patients with active Crohn’s disease (CD), and 15
healthy subjects. Tissue and circulating Treg cells were
also analyzed by flow cytometry.
Results. A significant up-regulation of IL-2,
TGF, FoxP3, STAT-5, and IL-10 transcripts in the
terminal ileum of AS patients displaying chronic ileal
inflammation was observed. Flow cytometric analysis
of Treg cells showed significant peripheral expansion
in both patients with AS and chronic inflammation
and patients with CD (mean  SD 1.08  0.4% and
1.05  0.3%, respectively) as compared with healthy
subjects (0.25  0.12%) (P < 0.05). Interestingly, a
5-fold increase in the proportion of Treg cells was
observed in the gut of patients with AS (5  3%) as
compared with healthy subjects (1.2  0.4%) (P <
0.001), with 70–80% of these cells also producing IL-10.
In vitro studies showed that blocking IL-10 was suffi-
cient to induce Th17 polarization on lamina propria
mononuclear cells isolated from AS patients.
Conclusion. Our findings provide the first evi-
dence that an active Treg cell response, mainly domi-
nated by IL-10 production, occurs in the gut of AS
patients and is probably responsible for the absence of
a clear Th17 polarization in the ileum of AS patients.
Intestinal inflammation is a shared feature of
ankylosing spondylitis (AS) and Crohn’s disease (CD).
Shared immunologic and genetic similarities, in both
clinical and preclinical stages, and the observation that
7% of patients with AS and initial chronic gut inflam-
mation develop overt CD strongly support the hypothe-
sis that AS patients with more pronounced gut inflam-
mation could be considered to have preclinical CD
(1–3).
We have recently demonstrated that overexpres-
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sion of interleukin-23 (IL-23), but not IL-17, is a pivotal
feature of subclinical gut inflammation in AS patients
(4). IL-23 has recently been shown to be a fundamental
player in the intestinal immune responses balanced
between tolerance and immunity. In particular, IL-23,
together with transforming growth factor  (TGF),
IL-1, and IL-6, has been demonstrated to be involved
in the differentiation of IL-17–producing CD4 T
cells, namely Th17 lymphocytes, that are highly pro-
inflammatory and induce the severe autoimmunity (5).
The participation of TGF in the differentiation of
Th17 cells places them in close relationship with
CD4CD25high Treg cells, since TGF, among its nu-
merous properties, is able to induce the expression of
FoxP3 in naive antigen-stimulated T cells in the peri-
pheral immune compartment, leading to cells with reg-
ulatory or suppressor functions (6).
Given the high levels of TGF transcripts we
observed in the gut of AS patients without concomitant
overexpression of IL-1 and IL-6, we aimed to investi-
gate whether the absence of a clear Th17 polarization,
despite the high levels of IL-23 observed, was related to
a Treg cell–mediated suppression in the gut of AS
patients. Herein, we provide the first evidence that levels
of CD4CD25high T cells are increased in the gut and in
the peripheral blood of AS patients, with a concomitant
significant intestinal increase in the levels of Treg cell–
related transcripts (STAT-5, TGF, and IL-10), suggest-
ing that an active Treg cell response, mainly dominated
by IL-10 production, occurs in AS. Thus, we propose
that the Treg cell response observed in the gut of AS
patients, which is keeping autoreactive Th17 cells under
check, is probably responsible for the absence of a clear
Th17 polarization despite the high levels of IL-23.
PATIENTS AND METHODS
Patients. Gut specimens and peripheral blood samples
from patients with CD, patients with AS, and control subjects
were consecutively obtained. The AS group consisted of 18
consecutive patients (11 men and 7 women), ages 19–48 years,
who had no clinical symptoms of bowel inflammation. Patients
were diagnosed according to the modified New York criteria
(7), and all of the patients were HLA–B27 positive. Disease
activity was evaluated using the Bath AS Disease Activity
Index (BASDAI) (8), with active disease defined as a BASDAI
score 4. The mean  SD BASDAI score at the time mucosal
biopsy specimens were obtained was 6.8  2.5. Mean  SD
disease duration since diagnosis was 4 2 months. At the time
of sample collection, 11 of the 18 AS patients were taking
nonsteroidal antiinflammatory drugs (NSAIDs).
The CD group consisted of 15 patients (9 men and 6
women), ages 20–50 years. Patients with pure colonic involve-
ment were excluded from the study. Disease activity in each
patient with CD was analyzed using the CD Activity Index (9)
and endoscopic and histopathologic data. Mean  SD disease
duration since diagnosis was 5  1.5 months. At the time of
sample collection, none of the patients in the CD group were
receiving corticosteroids or immunosuppressants. The mean
SD CD Activity Index score was 320  70 at the time of
enrollment.
The control group consisted of 15 normal subjects (12
men and 3 women), ages 41–68 years, who were undergoing
ileocolonoscopy for routine evaluation. Specimens from 10 of
the AS patients, 7 of the CD patients, and 7 controls in which
sufficient messenger RNA (mRNA) for new experiments was
available came from a previous study (4). Paired specimens for
histologic analysis, quantitative polymerase chain reaction
(PCR), and lamina propria mononuclear cell isolation for flow
cytometric analysis and functional assays were obtained from
new consecutively enrolled patients and controls (8 patients
with AS, 8 patients with CD, and 8 controls). Collection of ileal
biopsy specimens was approved by the ethics committee and
the institutional review board of the University of Palermo.
Histomorphologic grading. Tissue samples were pro-
cessed as previously described (4) and divided into 2 main
subgroups according to histologic features: samples with nor-
mal gut histologic features or minor inflammatory changes
(acute lesions) and samples with chronic inflammation.
Quantitative TaqMan reverse transcriptase–PCR
(RT-PCR) for Treg cytokines, FoxP3, and STAT-5 molecules
in ileal biopsy specimens. Total RNA was extracted using the
Qiagen RNeasy Mini kit, with on-column DNase I digestion.
A total of 1 g of RNA was reverse-transcribed to comple-
mentary DNA (cDNA) using a ThermoScript First-Strand
cDNA Synthesis kit (Invitrogen). For quantitative TaqMan
real-time PCR, gene expression assays for -actin or eu-
karyotic 18S control and for IL-1 (Hs00174097_m1), IL-2
(Hs00914135_m1), IL-6 (Hs00174131_m1), IL-10 (Hs00174086_
m1), IL-17A (Hs00174383_m1), TGF1 (Hs00171257_m1),
IL-23p19 (Hs00372324_m1), retinoid–related orphan recep-
tor C (RORC) (Hs01076112_m1), FoxP3 (Hs01085835_m1),
and STAT-5A (Hs00559647_m1) were obtained from Applied
Biosystems. Samples were run in triplicate at 20 ng of cDNA
per well and detected using an ABI Prism 7900HT instrument.
Results were analyzed using ABI Prism 7900HT Sequence
Detection System, version 2.1 software. Relative quantification
was assessed using the Ct method.
Immunohistochemistry for phospho–STAT-5. Immu-
nohistochemistry for phospho–STAT-5 was performed on
3-m–thick paraffin-embedded sections of intestinal biopsy
specimens obtained from patients and controls as previously
described (4). Briefly, following rehydration, antigen was un-
masked using the Dako Target retrieval solution (pH 6) for
45 minutes at 95°C. Endogenous peroxidase was blocked for
10 minutes with Dako Peroxidase blocking reagent, and non-
specific bindings were blocked for 20 minutes with Dako
Protein Block. The primary antibody, phosphorylated rabbit
monoclonal anti-human STAT-5 (Tyr694) (IgG; Cell Signaling)
was added (at a 1:300 dilution in Dako diluent) and incubated
for 1 hour at room temperature. An isotype-matched irrele-
vant antibody was used as a negative control. Slides were then
incubated for 30 minutes with peroxidase-conjugated Dako
EnVision polymer, peroxidase activity was visualized using
diaminobenzidine-positive chromogen (Dako), and slides were
lightly counterstained with hematoxylin before dehydration
and mounting in DePex (VWR International). The number of
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phospho–STAT-5–expressing cells was determined by count-
ing the immunoreactive cells on photomicrographs obtained
from 3 random high-power microscopic fields (400 magnifi-
cation) under a Leica DM2000 optical microscope using a
Leica DFC320 digital camera. Results are reported as the
mean  SD.
Culture media, reagents, and antibodies. In all in vitro
assays, cells were cultured in very low endotoxin medium
RPMI 1640 (Sigma), 10 mM HEPES (EuroClone), 10% fetal
bovine serum (EuroClone), 100 units/ml of penicillin/
streptomycin, and 0.05 mM 2-mercaptoethanol (Sigma). Phos-
phate buffered saline (PBS) was obtained from EuroClone.
Purified recombinant human IL-6 (R&D Systems), phorbol
myristate acetate (PMA), and ionomycin (Sigma-Aldrich)
were used for in vitro culture assays.
The following antibodies were used for flow cytometric
analysis: fluorescein isothiocyanate (FITC)–conjugated anti-
CD4, FITC-conjugated anti-CD68, FITC-conjugated anti-
CD20, phycoerythrin (PE)–conjugated anti–IL-10, PE-
conjugated IgG isotype control monoclonal antibodies (all
from Becton Dickinson), allophycocyanin-conjugated anti–
IL-17 (Santa Cruz Biotechnology), and FITC-conjugated anti–
Ki-67 (Biocompare).
Isolation of lamina propria mononuclear cells and
peripheral blood mononuclear cells (PBMCs). Lamina propria
mononuclear cells were isolated from 8 gut biopsy specimens
from patients with AS, patients with CD, and healthy controls
as described by Van Damme et al (10). Briefly, the biopsy
samples were washed with PBS, transferred to fresh PBS, and
stirred for 20 minutes at 37°C to remove blood and debris.
Next, the samples were transferred to fresh PBS plus 1 mM
EDTA and stirred for another 60 minutes at 37°C to remove
intraepithelial cells. Subsequently, lamina propria mono-
nuclear cells were obtained by cutting the biopsy into frag-
ments of 1–5 mm3, which were then incubated for 3 hours at
37°C in type IV collagenase (25 units/ml; Sigma). No further
purification of the cell populations was performed, in order to
retain the maximum number of cells. The isolated cells were
counted and checked for viability using 0.1% trypan blue
(viability ranged from 90% to 94%). Fresh cell suspension was
either immediately analyzed by fluorescence-activated cell
sorting (FACS) or cultured for 7 days in RPMI complete
medium. On day 3, 50% of the culture medium was replaced by
fresh medium supplemented with cytokines. On day 7, cells
were harvested, and their phenotype was analyzed by flow
cytometry. In some experiments, cells were stimulated with
cytokines in the presence of anti–IL-10 antibody (10 g/ml) or
the respective rat IgG1 isotype control (10 g/ml). All cultures
were set up in triplicate.
PBMCs were isolated from heparinized blood samples
from all patients and controls by density-gradient centrifuga-
tion (Histopaque; Sigma). Cell viability (trypan blue dye
exclusion) was always 95%. Fresh cell suspension was either
immediately analyzed by FACS analysis or cultured for 7 days
in RPMI complete medium.
Flow cytometric analysis of surface and intracellular
antigens. Total cells were incubated with monoclonal anti-
bodies for 30 minutes on ice and washed twice in PBS
containing 0.1% (weight/volume) NaN3. After staining, the
cells were fixed with 1% (w/v) paraformaldehyde (Sigma) in
PBS for 30 minutes at room temperature before flow cytomet-
ric analysis. For intracellular staining, cells were stimulated
with PMA (1 g/ml) plus ionomycin (0.5 g/ml) for 4 hours.
After 2 hours, brefeldin A (10 g/ml; Sigma) was added. After
simulation, the cells were stained with cell surface antibodies,
fixed in 4% paraformaldehyde, permeabilized with 0.1% sapo-
nin (Sigma), and then stained with antibodies to intracellular
antigens. Three-color flow cytometry was performed using a
FACSCalibur instrument (Becton Dickinson). At least 50,000
cells (events) were acquired for each sample. Lamina propria
mononuclear cells were expressed as the percentage of cells
within the lymphocyte gate. The acquired data were analyzed
using the CellQuest software program (Becton Dickinson).
Th17 and Treg quantification. To determine the per-
centage of Treg cells, PBMCs and lamina propria mononuclear
cells were stained using FITC-labeled anti-CD4 and peridinin
chlorophyll A protein (PerCP)–labeled anti-CD25 and then
analyzed using a FACSCalibur instrument. Results were ex-
pressed as the percentage of CD4CD25high lymphocytes. As
suggested by Cao et al (11), Treg cells were defined as CD4
lymphocytes that showed higher expression of CD25 than
autologous CD8 cells and were activated in vitro with
phytohemagglutinin. To further characterize the phenotype
and function of Treg cells, the intracellular production of IL-10
was investigated in CD4CD25high cells from the peripheral
blood and lamina propria of patients and controls. IL-17–
producing T cells were determined in lamina propria mono-
nuclear cells by CD4 and IL-17 intracellular staining and
subsequent flow cytometric analysis using a FACSCalibur
instrument.
Cell cultures and stimulation assays. Lamina propria
mononuclear cells (1  105) were cultured in RPMI 1640
complete medium. Where indicated, 100 or 500 ng/ml of IL-6
(R&D Systems) or 10 g/ml of neutralizing anti–IL-10 (R&D
Systems) was added to the cultures. For culture with Dyna-
beads CD3/CD28 T cell Expander (Invitrogen Dynal), lamina
propria mononuclear cells were cultured in complete medium
alone or with various cytokines at a bead:cell ratio of 1:1 in
U-bottomed 96-well plates. After 7 days, cells were collected
and analyzed by flow cytometry.
CD4CD127CD25 and CD4CD127CD25 T
cell isolation and proliferation assay. Freshly isolated lamina
propria mononuclear cells from patients with AS were sepa-
rated into CD4CD127CD25 and CD4CD127CD25
cells by double selection, using a Treg cell isolation kit for
magnetic separation, according to the recommendations of
the manufacturer (Miltenyi Biotec). The resulting purity of
Treg cells was 90–95%, as determined by FACS analysis.
The proliferation assay was performed by incubating
CD4CD127CD25 T cells (1  105) with or without
allogeneic CD4CD127CD25 Treg cells in the presence of
Dynabeads CD3/CD28 T cell Expander in complete medium.
The cells were seeded at different T responder cell:Treg cell
ratios (1:1 and 1:0.5) in triplicate. After 3 days of culture, cells
were harvested and stained using PerCP-conjugated anti-
CD25 and FITC-conjugated anti–Ki-67 antibodies to evaluate
the percentage of proliferating cells. The data were acquired
using a FACSCalibur instrument and analyzed by the
CellQuest software program.
Statistical analysis. Student’s t-test or the nonpara-
metric Mann-Whitney test was used to calculate the statistical
significance between groups. Spearman’s rank correlation was
performed to correlate TGF and FoxP3 expression levels in
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both AS and CD patients. P values less than 0.05 were
considered significant.
RESULTS
Prevalence and histomorphologic evaluation of
subclinical intestinal inflammation in AS patients. Of
the 18 patients with active AS (mean BASDAI 6.8) who
underwent colonoscopy, evidence of subclinical intesti-
nal inflammation was observed in 14 (77%). In all cases,
microscopic inflammatory lesions were only observed in
the distal ileum. On the basis of gut histologic features
(12), patients with AS were divided into 2 main sub-
groups: those with normal histologic features or minor
inflammation (acute lesions) (10 patients) and those
with chronic inflammation (8 patients).
Overexpression of IL-23 mRNA in the gut of AS
patients without a clear Th17 polarization.Overexpression
of IL-23 and TGF, without a concomitant increase in
other proinflammatory cytokines (such as IL-6 or IL-1)
and a clear Th17 polarization previously described in AS
patients (4), was confirmed in the present study (data not
shown), suggesting a role for TGF independent of the
Th17 response. Subanalysis of AS patients showed no
differences in IL-23 expression or Th17 polarization be-
tween patients who were taking NSAIDs and those who
were not taking NSAIDs. Patients with CD displayed a
marked increase in IL-17A, IL-6, IL-1, and RORC ex-
pression as compared with controls (data not shown),
confirming the coexistence of IL-23 up-regulation and
Th17 responses in intestinal inflammation in CD.
Figure 1. Overexpression of Treg cell–related genes in mucosal biopsy specimens from patients with ankylosing
spondylitis (AS). Relative quantification (RQ) of mRNA for FoxP3 (A), interleukin-2 (IL-2) (B), STAT-5, (C), and
IL-10 (D) was assessed by TaqMan real-time polymerase chain reaction in ileal biopsy specimens obtained from 18
patients with Crohn’s disease (CD), 15 patients with AS (further divided into patients with no inflammation or acute
inflammation versus patients with chronic inflammation), and 15 healthy subjects (HS). Bars show the mean and SD.
NS  not significant.
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Increased expression of mRNA for IL-2, IL-10,
TGF, FoxP3, and STAT-5 in ileal biopsy specimens
from AS patients. Given the strong up-regulation of
TGF in AS patients without a concomitant Th17
polarization, we next investigated whether an up-
regulation of cytokines and transcription factors in-
volved in Treg cell immune responses could occur in the
inflamed ileum of AS patients. As previously demon-
strated (4), significant up-regulation of TGF was ob-
served in AS patients with chronic ileal inflammation
(4-fold increase compared with controls; P  0.01) and
in CD patients (3-fold increase compared with controls;
P  0.05) (data not shown). Overexpression of FoxP3
(Figure 1A) was also observed in patients with AS and
Figure 2. Correlation of levels of transforming growth factor  (TGF) with FoxP3 in patients with AS (A) and patients with
CD (B). There was a significant correlation between TGF and FoxP3 levels in AS patients, but not in CD patients, by
Spearman’s rank correlation test. See Figure 1 for other definitions.
Figure 3. Phospho–STAT-5 expression by infiltrating immune cells within inflammatory lesions in the terminal ileum of patients with
AS or CD. A–D, Representative photomicrographs showing 3-m–thick paraffin-embedded sections of distal ileal biopsy specimens
obtained from healthy subjects (A), patients with AS and normal histologic features or acute inflammation (B), patients with AS and
chronic inflammation (C), and patients with CD (D), stained for phospho–STAT-5. Abundant phospho–STAT-5 expression was
observed in a large number of mononuclear cells infiltrating the intestinal mucosa of samples from patients with AS and chronic
inflammation and from patients with CD, but not in samples from normal subjects or patients with AS displaying normal histologic
features or acute inflammation (original magnification  400). E, Number of phospho–STAT-5–positive cells in the mucosa. Results
are expressed as the number of positive cells per field. Data are shown as box plots. Each box represents the 25th to 75th percentiles.
Lines inside the boxes represent the median. Lines outside the boxes represent the 10th and the 90th percentiles. See Figure 1 for
definitions.
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chronic inflammation and patients with CD, but the
correlation between TGF and FoxP3 was statistically
significant only in AS patients (r  0.9, P  0.0001)
(Figures 2A and B), strongly suggesting that the high
levels of TGF observed could act as a Treg cytokine in
the chronic inflamed ileum in AS.
We next evaluated IL-2 and STAT-5 mRNA
expression. As shown in Figures 1B and C, significantly
higher levels of IL-2 and STAT-5 mRNA transcripts
were detected in both AS patients with chronic inflam-
mation and CD patients when compared with patients
with AS without inflammation, patients with AS with
acute inflammation, or normal controls, suggesting that the
IL-2/STAT-5 axis is functioning in AS and CD patients.
Finally, we investigated IL-10 mRNA expression.
In fact, the regulatory mechanism in the intestine that
has been best characterized to date seems to be IL-10
dependent. When compared with healthy subjects and
patients with AS and acute inflammation or normal
histologic features, IL-10 mRNA was significantly over-
expressed in patients with AS and chronic inflammation
and in patients with CD (Figure 1D) (P  0.001 for
healthy subjects versus patients with AS and chronic
inflammation and P  0.01 for healthy subjects versus
patients with CD), suggesting that an active Treg cell
response sufficient to overcome intestinal inflammatory
responses apparently occurs in gut inflammation in AS
but not in CD.
Increase in phospho–STAT-5–expressing cells in
ileal specimens from patients with AS and chronic
inflammation. STAT-5 signaling is important for FoxP3
expression and Treg cell function. Since this function of
STAT molecules is not reflected by transcript levels but
by their phosphorylation status, we next investigated
phospho–STAT-5 protein expression in ileal specimens
from patients with AS, patients with CD, and controls.
As shown in Figure 3, phospho–STAT-5–expressing
cells were rarely detected in the immune cell infiltrates
in controls and AS patients with normal histologic
features or acute inflammation (Figures 3A, B, and E)
but were abundant in patients with AS with chronic
inflammation and patients with CD (Figures 3C–E).
Expansion of IL-10–producing CD4CD25high
Treg cells in the gut of AS patients. First, we evaluated
the percentage of IL-10 cells in lymphoid B and
T cells and myeloid cells. As shown in Figure 4A, CD4
T cells were the main cellular sources of IL-10 in
patients with AS and chronic ileal inflammation. We
next evaluated by flow cytometric analysis the percent-
age of CD4CD25high Treg cells occurring in lamina
propria mononuclear cells in patients with AS, patients
with CD, and normal controls. Isolated cells were gated
for CD4 T cells, and the percentage of CD4CD25high
cells among CD4 cells was determined. Interestingly,
lamina propria mononuclear cells that were isolated
from gut biopsy specimens from AS patients with
chronic ileal inflammation showed a significantly higher
frequency of CD4CD25high Treg cells compared with
patients with AS without inflammation, patients with
CD, and healthy controls (mean  SD 5  3%; 1.12 
0.4%; 1.8  0.2%; and 1.2  0.4%, respectively; P 
0.001 for AS with chronic inflammation versus each of
the other groups) (Figure 4B).
Considering the increase in IL-10 mRNA expres-
sion in ileal biopsy specimens from AS patients, we also
evaluated IL-10 production by lamina propria–derived
Treg cells. Lamina propria mononuclear cells were
stained for CD4, CD25, and intracellular IL-10 after
PMA stimulation. The percentage of IL-10–producing
Treg cells was significantly higher in lamina propria
mononuclear cells from AS patients with chronic intes-
tinal inflammation (mean  SD 70  12%) than in
patients with AS without inflammation, patients with
CD, and healthy subjects (P  0.01, P  0.05, and P 
0.01, respectively) (Figure 4C).
Frequency of circulating CD4CD25 Treg cells
in the peripheral blood of patients with AS. In order to
determine whether an increased number of
CD4CD25 Treg cells in the gut of AS patients
reflects a systemic modulation of these cells in the
peripheral circulation, we analyzed PBMCs from pa-
tients with AS, patients with CD, and healthy subjects.
As shown in Figure 4D, flow cytometric analysis of Treg
cells showed significant peripheral expansion in AS
(mean  SD 1.08  0.4%) at levels similar to those
observed in CD patients (1.05  0.3%) as compared
with healthy subjects (0.25  0.12; P  0.05), indicating
that increased gut frequency of Treg in AS might not be
related to a local compartmentalization.
Lamina propria–derived CD4CD127CD25high
Treg cells from AS patients have a direct suppressive
effect on T cells. We next investigated the functional
properties of CD4CD25high Treg cells isolated from
the ileum of 8 normal subjects and 8 AS patients by
testing their ability to suppress the proliferative re-
sponses of allogeneic peripheral blood CD4CD25 T
responder cells from healthy subjects. Lamina propria
CD4CD127CD25 cells were selected by antibody-
coated magnetic microbeads, and their ability to sup-
press the proliferative responses of allogeneic peripheral
blood T responder cells to polyclonal CD3/CD28 T cell
receptor stimulation was tested in vitro. Isolated
CD4CD127CD25 T responder cells were stimu-
lated with anti-CD3/CD28 microbeads alone or in the
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presence of lamina propria CD4CD127CD25 cells
at different ratios. After 7 days, CD4 T cell prolifera-
tion was evaluated by flow cytometry. Treg cells from
patients with AS inhibited T responder cell proliferation
by a mean  SD of 81  2.64% at a 1:1 ratio (Figure
5A). At a ratio of 0.5 Treg cells to 1 T responder cell, the
percentage of inhibition was 56  4% (Figure 5A).
These data indicate that Treg cells from lamina propria
of AS patients have a normal direct suppressive effect on
the activation of T responder cells isolated from normal
individuals. Treg cells from patients with CD inhibited T
responder cell proliferation by an average of 77  4% at
a 1:1 ratio (Figure 5B). At a 0.5:1 ratio, the percentage
of inhibition was 51  6% (Figure 5B). Treg cells from
controls inhibited T responder cell proliferation by an
average of 78  5% at a 1:1 ratio (Figure 5C). At a 0.5:1
ratio the percentage of inhibition was 60 5.6% (Figure
5C).
Expansion of the intestinal Th17 population af-
ter blockade of IL-10 in AS patients. Given the high
transcript levels of IL-10 observed in AS patients, we
evaluated the effect of blocking this cytokine on the
intestinal Th17 population. Since the higher levels of
TGF and IL-23 were observed in the gut of AS
patients, we considered lamina propria mononuclear
cells from AS patients that were preactivated by these
cytokines.
The mean  SD frequency of IL-17–producing
CD4 T cells among CD4 T lymphocytes derived
from lamina propria mononuclear cells from AS patients
was 1.2  0.35%. Lamina propria mononuclear cells
from AS patients were cultured in the presence of
different concentrations of IL-6 alone (100 or 500
ng/ml), in the absence of exogenous IL-23 and TGF
with or without a neutralizing mouse anti-human IL-10
antibody. As shown in Figure 6, addition of IL-6 at 100
Figure 4. Increased frequency of CD4CD25high T cells in isolated lamina propria mononuclear cells (LPMCs) and peripheral blood
mononuclear cells (PBMCs) from patients with AS. Freshly isolated lamina propria mononuclear cells and PBMCs from 8 patients
with AS, 8 patients with CD, and 8 healthy subjects were stained with fluorescein isothiocyanate (FITC)–conjugated CD68,
FITC-conjugated CD20, FITC-conjugated CD4, phycoerythrin (PE)–conjugated CD25, or PE-conjugated IL-10 and analyzed by flow
cytometry. A, Percentages of IL-10–positive T and B lymphocytes and myeloid cells among isolated lamina propria mononuclear cells
from AS patients. B, Representative dot plot of CD4 versus CD25 among isolated lamina propria mononuclear cells from AS patients
and percentages of CD4CD25high cells among lamina propria CD4 T cells isolated from patients and controls. C, Representative
dot plot of CD4 versus IL-10 among lamina propria mononuclear cells from AS patients and percentages of IL-10–positive cells among
lamina propria CD4 cells isolated from patients and controls. D, Percentages of CD4CD25high cells among peripheral blood CD4
T cells isolated from patients and controls. Bars show the mean and SD. See Figure 1 for other definitions. Color figure can be viewed
in the online issue, which is available at http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1529-0131.
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ng/ml did not modify the frequency of Th17 cells,
whereas at 500 ng/ml IL-6 was sufficient to overcome
IL-10 blockade, inducing significant Th17 expansion.
Inhibition of IL-10 induced a significant expansion of
Th17 cells (5  0.25%; P  0.05) at levels similar to
those observed with the highest concentration of IL-6.
An additional effect on Th17 expansion was observed
when the highest concentrations of IL-6 were used
together with IL-10 blockade.
DISCUSSION
Regulation of immune intestinal homeostasis is
now thought to be dependent upon the functions of
CD4CD25 Treg cells. Treg cells play a fundamental
role in the maintenance of intestinal hyporesponsiveness
to luminal antigens through IL-10– and TGF-
dependent mechanisms (13). In the presence of a break-
down of this tolerance, as a result of impaired Treg cell
function or increased proinflammatory stimuli, inflam-
mation may occur. In inflammatory bowel diseases, for
example, the frequency of CD4CD25high cells varies
with disease activity, with active IBD being associated
with a contraction of the peripheral blood Treg cell pool
and an only moderate expansion in intestinal lesions,
which is numerically insufficient to compensate for local
inflammation (14).
We have recently demonstrated that overexpres-
sion of IL-23 and TGF, but not IL-17, is a pivotal
feature of gut inflammation in AS (4). TGF regulates
both the differentiation of inflammatory Th17 cells and
suppressive Treg cell subsets, with the concomitant
presence of proinflammatory cytokines favoring Th17
cell differentiation (5,15,16). On the basis of these
findings, we investigated whether the absence of a clear
Figure 6. Blocking of IL-10 induces expansion of the intestinal Th17
population in patients with AS. Lamina propria mononuclear cells
isolated from patients with AS were considered preactivated by
transforming growth factor  and IL-23 and cultured in the presence of
IL-6 at concentrations of 100 and 500 ng/ml, with or without a
neutralizing mouse anti-human IL-10 antibody. Addition of IL-6 at 100
ng/ml did not modify the frequency of Th17 cells, whereas 500 ng/ml of
IL-6 was sufficient to induce significant Th17 expansion. Inhibition of
IL-10 induced a significant expansion of Th17 cells at levels similar to
those observed with the highest concentration of IL-6. An additional
effect was observed when the highest concentrations of IL-6 were used
together with IL-10 blocking. Bars show the mean and SD of 6
independent experiments.   P  0.05 versus lamina propria mono-
nuclear cells cultured alone. See Figure 1 for definitions.
Figure 5. Lamina propria CD4CD127CD25 T cells from patients with AS suppress the proliferation of allogeneic peripheral
blood CD4CD25 T cells in vitro. Isolated allogeneic peripheral blood CD4CD25 T responder cells from healthy controls were
stimulated with anti-CD3/CD28 microbeads alone or in the presence of lamina propria CD4CD127CD25 cells from patients with
AS, patients with CD, and controls at the indicated ratios. After 5 days, CD4 T cell proliferation was evaluated by flow cytometry.
Representative results of 5 independent experiments performed using isolated lamina propria mononuclear cells from 3 patients with
AS (A), 3 patients with CD (B), and 3 controls (C) and peripheral blood mononuclear cells from 3 controls are shown. Bars show the
mean and SD proliferation of responder (R) cells cultured alone or in the presence of Treg cells (S) at 1:0.5 and 1:1 ratios. See Figure
1 for other definitions.
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Th17 polarization, despite the high levels of IL-23
observed, could be due to a Treg cell–mediated suppres-
sion in the gut of AS patients.
This is the first study to show that Treg cell–
related cytokines and transcription factor expression
are markedly up-regulated at the mRNA level in intes-
tinal inflammation in patients with AS. IL-2 mRNA
overexpression in CD patients and in AS patients was
associated with the up-regulation of STAT-5 (the main
transducer of IL-2 signaling upon IL-2 receptor [IL-2R]
ligation), FoxP3, and IL-10, indirectly suggesting that
the IL-2/STAT-5 axis is functional in AS and CD
patients.
The interaction of IL-2 with IL-2R is critically
required to promote thymic and peripheral Treg devel-
opment, in part by up-regulation of FoxP3 and CD25
(17,18). IL-2 signaling via STAT-5 has been demon-
strated to constrain Th17 differentiation (19). Interest-
ingly, although overexpression of FoxP3 was observed in
both AS and CD patients, a significant positive correla-
tion between TGF and FoxP3 was found only in AS
patients, strongly suggesting that the high levels of
TGF observed in AS could function as a Treg cytokine
in the inflamed ileum. The different inflammatory mi-
lieus occurring in the ileum of AS and CD patients,
despite the similar levels of TGF in these patients,
could support divergent immunomodulatory mecha-
nisms for TGF in AS and in CD, being proinflamma-
tory in the latter. TGF induces differentiation of naive
T cells into either Th17 cells or Treg cells in a dose-
dependent manner, with high levels of TGF inhibiting
Th17 response (15). In particular, it has recently been
demonstrated that a functionally specialized popula-
tion of mucosal CD103 dendritic cells (DCs) induces
FoxP3 Treg cells via a TGF-dependent mechanism
(20). However, we cannot exclude the possibility that
TGF produced by Treg cells themselves could contrib-
ute to the increased expression observed in the inflamed
ileum. In this regard, the specific role of the DCs of AS
patients in inducing Treg cell differentiation and the
contribution of single cell types in TGF production
need to be better investigated.
In this study, we have further expanded the
understanding of the immunoregulatory properties of
CD4CD25high Treg cells by demonstrating that there
are increased numbers of Treg cells, with preserved
immunosuppressant activity, together with overexpres-
sion of Treg cell–related cytokines and transcription
factors at the mRNA level in the inflamed ileum of
AS patients. The increased prevalence of Treg cells,
together with the demonstration of the absence of a
clear Th1 or Th17 polarization, strongly indicates the
importance of Treg cells in the maintenance of intes-
tinal homeostasis in an early stage of chronic gut in-
flammation.
The importance of either IL-10 or IL-10R2 has
been demonstrated in both human colitis and murine
models of colitis (21–24). Cure of murine colitis by
CD4CD25high Treg cells has also been shown to be
dependent on IL-10, with IL-10–producing CD4
CD25high Treg cells selectively enriched within the co-
lonic lamina propria, suggesting compartmentalization
of the Treg cell response at effector sites (25).
The evidence of IL-2, IL-10, and STAT-5 over-
expression in mucosal biopsy specimens from patients
with AS and, to a lesser extent, patients with CD
observed in the present study, together with the obser-
vation that 70–80% of the lamina propria Treg cells are
also IL-10–producing cells, suggests a key role of IL-10
in modulating intestinal immune response, which is
insufficient to control inflammation in CD, but is indis-
pensable in AS. Furthermore, our demonstration of a
significant Th17 expansion from isolated lamina propria
mononuclear cells obtained from AS patients, in the
presence of IL-10 inhibition, strongly supports the key
role of IL-10 in preventing the onset of a clear Th17
polarization.
The exact mechanism by which a breakdown in
immune regulatory networks leads to chronic inflamma-
tory diseases in the intestines of AS patients is currently
unknown. We hypothesize that in genetically prone
subjects, an unknown infective stimulus could induce the
production of proinflammatory cytokines, such as IL-6
or IL-1, down-regulating Treg cell responses with the
occurrence of active differentiation of pathogenic Th17
cells. In this context, the high levels of IL-23 occurring in
the gut of AS patients could sustain the Th17 commit-
ment, leading to the development of gut inflammation.
In summary, this is the first study to demonstrate
that Treg cells are activated in the terminal ileum in AS
patients. This response is probably responsible for the
absence of a clear Th17 polarization despite the high
levels of IL-23 observed in the intestine of AS patients.
Up-regulation of IL-2, STAT-5, and IL-10 confirms a
key role of IL-10 in the maintenance of gut immune
homeostasis, strongly suggesting the potential of strate-
gies involving the IL-10 pathway to restore intestinal
homeostasis in human intestinal inflammation.
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